# BioSerenity

> Connected medical devices and AI\-enhanced diagnostics for neurology, sleep medicine, and cardiology \-\- enabling at\-home health monitoring and life insurance underwriting

## At a glance

| Field | Value |
| --- | --- |
| Category | Underwriting & Risk |
| Type | Solutions Provider |
| Region | EMEA |
| Headquarters | Paris, France |
| Founded | 2014 |
| Stage | Growth |
| Employees | 201-500 |
| Funding | Series C+ |

## Overview

BIOSerenity is a French leader in electrophysiological diagnostics, combining vertically integrated connected medical devices with an AI-enhanced diagnostic platform for neurology, sleep medicine, and cardiology. Founded in 2014 by Pierre-Yves Frouin and incubated at the ICM Institute (Institut du Cerveau et de la Moelle epiniere) in Paris, the company has grown to conduct over 45,000 EEGs, 8,000 polysomnographies (PSGs), and 5,000 ECGs annually, serving more than 150,000 patients per year through approximately 300 clinical partners.

In November 2025, Emmanuel Mougeotte (former CEO of CompuGroup Medical France) became CEO, succeeding Pierre-Yves Frouin who concluded his tenure in January 2026. BIOSerenity has raised approximately USD 121 million across four funding rounds.

BIOSerenity has a direct insurance dimension: SCOR (the global reinsurer) is a strategic investor, and the company's Cardiophy Check-up service has been deployed as an at-home life insurance underwriting tool by a leading French insurance distributor. This positions BIOSerenity at the intersection of health diagnostics and life insurance underwriting.

## Products & services

### Neuronaute\+

Next-generation compact, modular connected EEG device for ambulatory neurological monitoring. FDA-cleared and CE-marked.

**Key features:**

- Modular design compatible with EEG caps \(IceCap\)
- Wireless connectivity for remote data transmission
- AI\-powered signal analysis
- Suitable for 72\-hour home EEG recordings

*Target users:* Neurologists, neuropediatricians, hospital EEG departments

### IceCap

Disposable EEG electrode caps compatible with existing EEG equipment. FDA-cleared for neonatal, pediatric, and adult patients.

**Key features:**

- Easy setup \-\- approximately half the time of a traditional 10\-20 system
- Available in multiple sizes
- Cost\-effective disposable design for ICU and clinical settings

*Target users:* ICU clinicians, EEG technologists

### Neurophy

On-demand EEG-as-a-service for ambulatory and remote neurological diagnostics.

**Key features:**

- Remote EEG interpretation by specialists
- Covers routine and emergency EEG
- Integrated with Neuronaute\+ device

*Target users:* Neurologists, hospital outpatient services

### Somnophy

Remote sleep disorder diagnostic service combining polysomnography devices with AI-assisted analysis.

**Key features:**

- Home\-based PSG recording
- AI model for sleep disorder classification \(developed with Stanford University\)
- Remote specialist interpretation

*Target users:* Sleep medicine specialists, pulmonologists

### Cardiophy

Remote cardiac monitoring service for ECG and Holter recordings.

**Key features:**

- Short ECG and extended Holter monitoring \(24 hours to 4 weeks\)
- 5x greater chance of detecting atrial fibrillation vs\. standard 24\-hour Holter
- Nurse\-assisted patient support and cardiologist interpretation
- \*\*Cardiophy Check\-up:\*\* At\-home life insurance underwriting application deployed by French insurers in partnership with SCOR

*Target users:* Cardiologists, life insurance distributors, policyholders

### Large Brain Model \(LBM\)

Proprietary foundation AI model trained on over a decade of EEG recordings, providing clinical decision support for electrophysiology.

**Key features:**

- Foundation model approach applied to EEG signal interpretation
- Developed from 10\+ years of proprietary data
- Supports diagnostic AI tools across the product suite

*Target users:* Internal \(embedded in Neurophy, Somnophy, Cardiophy platforms\)

## Category & focus

- Subcategories: Life insurance underwriting, connected health diagnostics, IoMT \(Internet of Medical Things\)
- Insurance verticals: Life & Annuity, Health
- Target customers: Carriers, Reinsurers, Consumers

## Notable customers

- SCOR \(strategic insurance investor and life underwriting partner\)
- Unnamed leading French insurance distributor \(Cardiophy Check\-up deployment\)
- Lille University Hospital \(advisory board\)
- Nancy University Hospital \(advisory board\)
- Stratus Neuro \(US distribution partner for IceCap, April 2025\)

## Links

- Website: <https://bioserenity.com>
- Directory profile: <https://insurtechlist.com/companies/bioserenity/>
- Icecap: <https://bioserenity.com/icecap/>
- Research: <https://bioserenity.com/research/>
- Cardiophy: <https://bioserenity.com/cardiophy/>
- Neuronaute\+: <https://bioserenity.com/neuronaute/>
- Press releases: <https://bioserenity.com/press-release/>
- Scor follow\-on \(2022\): <https://www.scor.com/en/news/scor-makes-follow-investment-bioserenity>
- Scor investment \(2019\): <https://www.scor.com/en/news/scor-invests-bioserenity>
- Jolt capital eur 24m \(2023\): <https://www.jolt-capital.com/news/jolt-capital-invests-24-million-in-bioserenity>
- Stratus us partnership \(2025\): <https://stratusneuro.com/stratus-to-become-us-distributor-of-icecap/>

---

*Last updated: 2026\-05\-11*